Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Mayo Clinic
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Meet the criteria for 1.3 chronic migraine based on ICHD3 criteria.
Currently receiving onabotulinumtoxinA per PREEMPT protocol for the treatment of chronic migraine.
Patient is willing and able to comply with the protocol to the satisfaction of the investigator.
Patient has the capacity to provide written, informed consent for themselves.
You may not be if
Participants with an active implanted electrical and/or neurostimulator device (e.g., cardiac pacemaker, cochlear implant).
Participants with congestive heart failure (CHF), severe cardiac or cerebrovascular disease.
Participants with uncontrolled epilepsy.
Pregnant, trying to get pregnant or breastfeeding female participants.
Subjects participating in any other interventional clinical study.
Participants with other significant pain, medical or psychological problems that in the opinion of the investigator may confound the study assessments.
Participants who have previous experience with the device.
Patients with cranial deformities, prior cranial surgeries with violation of the calvarium, or shunt placement.
Patients receiving concurrent nerve blocks or trigger point injections within the same visit
Clareo Health | A Study of Remote Electrical Neuromodulation for Acute Procedural Pain
